Larotrectinib Sulfate and Minocycline Extended-Release Tablets
Determining the interaction of Larotrectinib Sulfate and Minocycline Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: minocycline
Brand name: Dynacin, Minocin, Minocin PAC, Minolira, Solodyn, Ximino, Vectrin, Myrac
Synonyms: Minocycline, Minocycline (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Sulfate-Minocycline Hydrochloride
- Larotrectinib Sulfate-Minocycline Hydrochloride eent
- Larotrectinib Sulfate-Minocycline Hydrochloride Periodontal Microspheres
- Larotrectinib Sulfate-Minocycline Injection
- Larotrectinib Sulfate-Minocycline Intravenous
- Larotrectinib Sulfate-Minocycline mucous membrane powder
- Minocycline Extended-Release Tablets-Lartruvo
- Minocycline Extended-Release Tablets-Larynex
- Minocycline Extended-Release Tablets-Laryng-O-Jet
- Minocycline Extended-Release Tablets-Laryngesic
- Minocycline Extended-Release Tablets-Lasix
- Minocycline Extended-Release Tablets-Lasix Injection